Menu Search
Equities

PHC Holdings Corp

2GY:DUS

PHC Holdings Corp

Actions
  • Price (EUR)6.15
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change-26.35%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024 15:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

PHC Holdings Corp is a Japan-based company mainly engaged in the development, manufacture and sale of healthcare devices and services. The Company operates through three business segments. The Diabetes Management segment is involved in the development, manufacture and sale of in vitro diagnostic equipment such as self-monitoring blood glucose systems and point-of-care testing (POCT) products and electric drug injectors. The Healthcare Solutions segment is involved in the development and sale of medical information technology (IT) products such as receipt computers and electronic medical records, as well as the development of clinical laboratory diagnosis business. The Diagnostic and Life Science segment is involved in the development, manufacture and sale of research and medical support equipment, pathological diagnosis equipment, among others.

  • Revenue in JPY (TTM)360.94bn
  • Net income in JPY-6.34bn
  • Incorporated2014
  • Employees9.25k
  • Location
    PHC Holdings Corp2-38-5, Nishi-shimbashiCHIYODA-KU 100-0006JapanJPN
  • Phone+81 354087280
  • Websitehttps://www.phchd.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.